Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Cyclic peptides
Reexamination Certificate
2005-03-29
2009-02-17
Tsang, Cecilia (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Cyclic peptides
Reexamination Certificate
active
07491794
ABSTRACT:
The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
REFERENCES:
patent: 5624949 (1997-04-01), Heath et al.
patent: 5656627 (1997-08-01), Bemis et al.
patent: 5756466 (1998-05-01), Bemis et al.
patent: 5847135 (1998-12-01), Bemis et al.
patent: 6858600 (2000-02-01), Hamilton et al.
patent: 6268207 (2001-07-01), Bailey
patent: 6323180 (2001-11-01), Llinas-Brunet et al.
patent: 6410531 (2002-06-01), Llinas-Brunet et al.
patent: 6420380 (2002-07-01), Llinas-Brunet et al.
patent: 6534523 (2003-03-01), Llinas-Brunet et al.
patent: 6608027 (2003-08-01), Tsantrizo et al.
patent: 6642204 (2003-11-01), Llinas-Brunet et al.
patent: 6693072 (2004-02-01), Gallion et al.
patent: 6767991 (2004-07-01), Llinas-Brunet et al.
patent: 6828301 (2004-12-01), Chen et al.
patent: 6846802 (2005-01-01), Chen et al.
patent: 6867185 (2005-03-01), Campbell et al.
patent: 6867303 (2005-03-01), Grela
patent: 6869964 (2005-03-01), Campbell et al.
patent: 6872805 (2005-03-01), Campbell et al.
patent: 6878722 (2005-04-01), Campbell et al.
patent: 6909000 (2005-06-01), Farmer et al.
patent: 6914122 (2005-07-01), Venkatraman et al.
patent: 6919423 (2005-07-01), Llinas-Brunet
patent: 6995174 (2006-02-01), Wang et al.
patent: 7012066 (2006-03-01), Saksena et al.
patent: 7041698 (2006-05-01), Ripka et al.
patent: 7091184 (2006-08-01), Llinas-Brunet et al.
patent: 7119072 (2006-10-01), Llinas-Brunet et al.
patent: 7125845 (2006-10-01), Wu et al.
patent: 7132504 (2006-11-01), Scola et al.
patent: 7135462 (2006-11-01), Scola et al.
patent: 7148347 (2006-12-01), Brandenburg et al.
patent: 7157424 (2007-01-01), Chen et al.
patent: 7173004 (2007-02-01), McPhee et al.
patent: 7173057 (2007-02-01), Chen et al.
patent: 7176208 (2007-02-01), Nakajima et al.
patent: 7183374 (2007-02-01), Brenner et al.
patent: 7186747 (2007-03-01), Arasappan et al.
patent: 7189844 (2007-03-01), Gallou et al.
patent: 7208600 (2007-04-01), Cottrell et al.
patent: 7273851 (2007-09-01), Miao et al.
patent: 7273885 (2007-09-01), Pitlik et al.
patent: 7309708 (2007-12-01), Tu et al.
patent: 2002/0016294 (2002-02-01), Venkatraman et al.
patent: 2002/0016442 (2002-02-01), Llinas-Brunet et al.
patent: 2002/0037998 (2002-03-01), Llinas-Brunet et al.
patent: 2002/0107181 (2002-08-01), Chen et al.
patent: 2002/0111313 (2002-08-01), Campbell et al.
patent: 2003/0181363 (2003-09-01), Llinas-Brunet et al.
patent: 2003/0186895 (2003-10-01), Llinas-Brunet et al.
patent: 2003/0191067 (2003-10-01), Llinas-Brunet et al.
patent: 2003/0195228 (2003-10-01), Chen et al.
patent: 2003/0224977 (2003-12-01), Llinas-Brunet et al.
patent: 2004/0002448 (2004-01-01), Tsantrizos et al.
patent: 2004/0033959 (2004-02-01), Chen et al.
patent: 2004/0038872 (2004-02-01), Campbell et al.
patent: 2004/0048802 (2004-03-01), Ripka et al.
patent: 2004/0072761 (2004-04-01), Campbell et al.
patent: 2004/0077551 (2004-04-01), Campbell et al.
patent: 2004/0106559 (2004-06-01), Wang et al.
patent: 2004/0138109 (2004-07-01), Chen et al.
patent: 2004/0180815 (2004-09-01), Nakaima et al.
patent: 2004/0229776 (2004-11-01), Chen et al.
patent: 2004/0229777 (2004-11-01), Cerreta et al.
patent: 2004/0248779 (2004-12-01), Dersch et al.
patent: 2004/0266668 (2004-12-01), Nakajima et al.
patent: 2005/0049187 (2005-03-01), Brandenburg et al.
patent: 2005/0065073 (2005-03-01), Wu et al.
patent: 2005/0075279 (2005-04-01), Llinas-Brunet et al.
patent: 2005/0080005 (2005-04-01), Llinas-Brunet et al.
patent: 2005/0090432 (2005-04-01), McPhee et al.
patent: 2005/0119189 (2005-06-01), Cottrell et al.
patent: 2005/0119453 (2005-06-01), Brenner et al.
patent: 2005/0136400 (2005-06-01), Lin et al.
patent: 2005/0143316 (2005-06-01), Tu et al.
patent: 2005/0153877 (2005-07-01), Miao et al.
patent: 2005/0153900 (2005-07-01), Velazquez et al.
patent: 2005/0197301 (2005-09-01), Njoroge et al.
patent: 2005/0209135 (2005-09-01), Busacca et al.
patent: 2005/0215486 (2005-09-01), Cottrell et al.
patent: 2005/0222047 (2005-10-01), Chen et al.
patent: 2005/0245458 (2005-11-01), Arasappan et al.
patent: 2005/0261200 (2005-11-01), Miao et al.
patent: 2005/0267040 (2005-12-01), Scola et al.
patent: 2005/0267043 (2005-12-01), Bogen et al.
patent: 2005/0272663 (2005-12-01), Arasappan et al.
patent: 2006/0046956 (2006-03-01), Sannigrahi et al.
patent: 2006/0122123 (2006-06-01), Chaudhary et al.
patent: 2006/0183694 (2006-08-01), Sin et al.
patent: 2006/0210969 (2006-09-01), Rice et al.
patent: 2007/0054842 (2007-03-01), Blatt et al.
patent: 2007/0093414 (2007-04-01), Carini et al.
patent: 2007/0161574 (2007-07-01), Rosenquist et al.
patent: 2370400 (2003-08-01), None
patent: 01958-1996 (1997-07-01), None
patent: REG. 39715 (1998-06-01), None
patent: 01184-1998 (1999-03-01), None
patent: WO 97/18207 (1997-05-01), None
patent: WO 98/51665 (1998-11-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: WO 00/59929 (2000-10-01), None
patent: WO 01/74768 (2001-10-01), None
patent: WO 01/81325 (2001-11-01), None
patent: WO 02/18369 (2002-03-01), None
patent: WO 02/060926 (2002-08-01), None
patent: WO 03/062265 (2003-07-01), None
patent: WO 03/064416 (2003-08-01), None
patent: WO 03/064455 (2003-08-01), None
patent: WO 03/064456 (2003-08-01), None
patent: WO 03/099274 (2003-12-01), None
patent: WO 2004/026896 (2004-04-01), None
patent: WO 2004/039833 (2004-05-01), None
patent: WO 2004/096286 (2004-11-01), None
patent: WO 2004/113365 (2004-12-01), None
patent: WO 2005/010029 (2005-02-01), None
patent: WO 2005/046712 (2005-05-01), None
patent: WO 2005/051410 (2005-06-01), None
patent: WO 2005/073195 (2005-08-01), None
patent: WO 2005/073216 (2005-08-01), None
patent: WO 2005/107745 (2005-11-01), None
patent: WO 2005/113581 (2005-12-01), None
patent: WO 2006/020276 (2006-02-01), None
patent: WO 2006/043145 (2006-04-01), None
patent: WO 2006/086381 (2006-08-01), None
patent: WO 2007/015824 (2007-02-01), None
patent: WO 2007/044893 (2007-04-01), None
patent: WO 2007/044933 (2007-04-01), None
A. Marchetti et al., “Synthesis of Two Novel Cyclic Biphenyl Ether Analogs of an Inhibitor of HCV NS3 Protease”,Synlett.1999, S1, 1000-1002.
A. Faucher et al., “Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans,” Organic Letters (2004), 6(17), 2901-2904.
S. LaPlante et al., “Dynamics and structure-based design of drugs targeting the critical serine protease of the hepatitis C virus from a peptidic substrate to BILN 2061”, Current Medicinal Chemistry: Anti-Infective Agents (2005), 4(2), 111-132 (Abstract Only).
D. Thibeault et al., “Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061”, Journal of Virology (2004), 78(14), 7352-7359.
N. Goudreau et al., “Potent Inhibitors of the Hepatitis C Virus NS3 Protease: Design and Synthesis of Macrocyclic Substrate-Based β-Strand Mimics,” Journal of Organic Chemistry (2004), 69(19), 6185-6201.
L. Lu et al., “Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro,” Antimicrobial Agents and Chemotherapy (2004), 48(6), 2260-2266.
H. Hinrichsen et al., “Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients,” astroenterology (2004), 127(5), 1347-1355.
Ni, Zhi-Jie; Wagman, Allan S., “Progress and development of small molecule HCV antivirals,” Current Opinion in Drug Discovery & Development (2004), 7(4), 446-459. (Abstract only).
Tsantrizos, Youla S., “The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2
Andrews Steven W.
Blatt Lawrence M.
Condroski Kevin R.
Jiang Yutong
Kennedy April L.
Bendrick John
Heard Thomas S
Intermune, Inc.
Knobbe Martens Olson & Bear LLP
Tsang Cecilia
LandOfFree
Macrocyclic compounds as inhibitors of viral replication does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrocyclic compounds as inhibitors of viral replication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic compounds as inhibitors of viral replication will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4096201